ArticleActa pharmaceutica Sinica. B2025

STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation.

Chengfei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.